[1] |
LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu.
Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
|
[2] |
JIAO Yuzhu, YANG Qing.
Update of treatment of pyoderma gangrenosum
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
|
[3] |
ZHANG Ying, NIU Xuping.
Update of targeted treatment of pemphigus
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 221-224.
|
[4] |
HU Mingyu, XU Weiwei, ZHOU Pengpeng, TANG Junting.
Erythema elevatum diutinum associated with multiple systemic damage: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 124-126.
|
[5] |
DENG Yazhi, KANG Xiaojing, DING Yuan.
Update of correlation between psoriasis and malignant tumors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 139-144.
|
[6] |
MAN Chunhua, WANG Xianzhen, WANG Xiangtong, LI Yangyang, WANG Qing.
Effect of abrocitinib in a patient with secukinumab-induced eczematous eruption: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 56-58.
|
[7] |
ZHANG Kun, CHEN Lixiu.
Bullous pemphigoid with positive pemphigus antibody in erythroderma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 606-608.
|
[8] |
YANG Luan, WEN He, SUN Qing.
Pathogenesis and therapeutic advances of drug induced hypersensitivity syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 538-542.
|
[9] |
HUAI Pengcheng, LI Zhen, LI Jinghui, MA Yanpeng, YANG Baoqi, LIU Jing, SUN Yonghu, YU Gongqi, LIU Tingting, SUN Yuanhang, WANG Meng, LI Zige, LIU Jun, ZHANG Zhaosheng, ZHAO Wei, LI Congcong, LIU Hong, ZHANG Furen.
Emergency response report of a positive COVID-19 nucleic test elderly inpatient
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 393-396.
|
[10] |
GU Duoduo, PAN Ruoxin, ZHANG Yue, LI Min, TAO Meng, XU Yang.
Update of the mast cells and mast cell stabilizers in pathogenesis and treatment of rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 451-455.
|
[11] |
FANG Meng, JIA Fengming, LIU Hong.
Update of treatment of psoriasis in pregnancy
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 142-147.
|
[12] |
LONG Boquan, YANG Lan, MA Pingping, LAI Huijun, DOU Shuhui, CAI Chuanchuan, GUO Hongwei, LI Ding.
Rituximab in the treatment of systemic lupus erythematosus with blood crisis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 898-900.
|
[13] |
QIN Xinrui, ZHANG Shun, XUE Bin.
Update of treatment of cutaneous squamous cell carcinoma
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 929-935.
|
[14] |
WANG Licheng, CHEN Dongke, ZHU Xiong, LIN Yujin, ZHONG Shan, HE Lyufen.
Primary cutaneous cryptococcosis and literature review: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 752-755.
|
[15] |
YAN Hongxia, HUA Ri, JIA Xiujuan, WANG Bailing, GAO Zhiqing, ZHANG Xiaofeng, WU Fenglan, MU Qiri.
Update of TRPV1 in the pathogenesis and treatment of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(10): 770-773.
|